Skip to main content
Equibles
TECH logo

TECH · BIO-TECHNE Corp · Analyst Estimates

Track TECH — free

Use TECH with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TECH.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$72.55 -0.07 (-0.10%) At close · Oct 23
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$11.38B
Shares
156.82M
Volume · Oct 23 1.9M Avg daily vol (3M) 3.03M

Analyst Estimates

Compare analyst forecasts for BIO-TECHNE Corp across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-24 01:02 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2027-06-30

Analyst estimates for FY ending 2027-06-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
1.82
2.04
2.15
13
2.04
2.02
2.04
2.05
0
0
2
2
Revenue
USD
Publication date not stated
1.25B
1.27B
1.29B
12
 — — — — — — — —

FY ending 2028-06-30

Analyst estimates for FY ending 2028-06-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
2.03
2.31
2.60
9
2.31
2.31
2.32
2.30
0
0
3
3
Revenue
USD
Publication date not stated
1.35B
1.40B
1.50B
9
 — — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.41
0.45
0.49
7
0.45
0.43
0.44
0.44
0
0
1
1
Revenue
USD
Publication date not stated
287.10M
292.20M
298.00M
8
 — — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.46
0.48
0.51
6
0.48
0.47
0.48
0.48
0
0
1
1
Revenue
USD
Publication date not stated
303.67M
307.78M
313.28M
7
 — — — — — — — —
Key facts CIK 842023 CUSIP 09073M104 13F (30d) 99 filings 94 filers Visit website Investor relations